{
    "organizations": [],
    "uuid": "f164e5fb308bccdd41c8dfbe41df258ebbaf977d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aldeyra-therapeutics-announces-yea/brief-aldeyra-therapeutics-announces-year-end-2017-financial-results-idUSASC09U6B",
    "ord_in_thread": 0,
    "title": "Aldeyra Therapeutics Announces Year End 2017 Financial Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Aldeyra Therapeutics Inc:\n* ALDEYRA THERAPEUTICS ANNOUNCES YEAR END 2017 FINANCIAL RESULTS\n* ALDEYRA THERAPEUTICS INC - CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES WERE $42.9 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-29T19:57:00.000+03:00",
    "crawled": "2018-03-29T15:02:29.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "aldeyra",
        "therapeutic",
        "inc",
        "aldeyra",
        "therapeutic",
        "announces",
        "year",
        "end",
        "financial",
        "result",
        "aldeyra",
        "therapeutic",
        "inc",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "million",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}